Patient Square Capital’s BeOne Medicines ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$12.3M Sell
33,500
-56,520
-63% -$19.3M 1.96% 13
2026
Q2
$25.7M Buy
90,020
+9,478
+12% +$2.79M 3.97% 5
2026
Q1
$23.9M Buy
80,542
+11,230
+16% +$3.64M 4.24% 4
2025
Q4
$21.1M Buy
+69,312
New +$22.7M 4.51% 5

Other funds holding ONC

Patient Square Capital's ONC Position: Q3 2026 in Review

Patient Square Capital reduced its BeOne Medicines (ONC) stake by 63% in Q3 2026, selling an estimated $19.3M and leaving 33,500 shares worth $12.3M. The position accounts for 1.96% of the portfolio, ranked #13.

Patient Square Capital first reported a position in ONC in Q4 2025 and has held it in 4 quarters since. The position peaked at $25.7M in Q2 2026. 323 funds tracked by Wall St. Rank hold ONC as of Q3 2026.

  • Patient Square Capital held 33,500 shares of BeOne Medicines worth $12.3M as of Q3 2026.
  • Patient Square Capital sold 56,520 BeOne Medicines shares in Q3 2026, an estimated $19.3M.
  • BeOne Medicines made up 1.96% of Patient Square Capital's portfolio in Q3 2026, its #13 holding.
  • Patient Square Capital first reported a position in BeOne Medicines in Q4 2025 and has held it in 4 quarters since.
  • Patient Square Capital's BeOne Medicines position peaked at $25.7M in Q2 2026.
  • 323 funds tracked by Wall St. Rank held BeOne Medicines as of Q3 2026.

Based on Patient Square Capital's 13F filing for Q3 2026, filed 10 Nov 2026.